Go Pro
NASDAQ:AQB

AquaBounty Technologies Q2 2025 Earnings Report

AquaBounty Technologies logo
$1.14 +0.01 (+0.88%)
As of 09/18/2026 04:00 PM Eastern

AquaBounty Technologies EPS Results

Actual EPS
-$0.63
Consensus EPS
-$0.53
Beat/Miss
Missed by -$0.10
One Year Ago EPS
N/A

AquaBounty Technologies Revenue Results

Actual Revenue
N/A
Expected Revenue
$0.50 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

AquaBounty Technologies Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

AquaBounty Technologies' next earnings date is estimated for Tuesday, November 10, 2026, based on past reporting schedules.

Conference Call Resources

AquaBounty Technologies Earnings Headlines

Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
AquaBounty Technologies Inc.
See More AquaBounty Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like AquaBounty Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AquaBounty Technologies and other key companies, straight to your email.

About AquaBounty Technologies

AquaBounty Technologies (NASDAQ:AQB) is a biotechnology and aquaculture company focused on developing sustainable methods for producing seafood. Its work centers on land-based, closed-containment aquaculture systems that use recirculating water technology to raise fish while reducing reliance on coastal sites and limiting exposure to environmental contaminants.

The company’s principal product is AquAdvantage Salmon, a genetically engineered Atlantic salmon developed to reach market size more quickly than conventional Atlantic salmon. AquAdvantage Salmon became the first genetically engineered animal approved by the U.S. Food and Drug Administration for use as food. AquaBounty has also conducted research and development involving salmon production systems, breeding technology and other aquaculture applications.

Founded in 1991, AquaBounty has pursued commercial salmon production in the United States and has maintained research and development activities in North America. Its strategy has emphasized producing salmon closer to consumer markets through land-based facilities, potentially reducing transportation requirements and improving supply-chain control. The company is headquartered in the United States and has historically operated research and production activities in the U.S. and Canada.

View AquaBounty Technologies Profile